23andMe to Report FY2024 First Quarter Financial Results
SOUTH SAN FRANCISCO, Calif., July 25, 2023 (GLOBE NEWSWIRE) — 23andMe Holding Co. (Nasdaq: ME)…
Month: July 2023
IO Biotech Announces Abstract Accepted for Mini Oral Presentation at IASLC 2023 World Conference on Lung Cancer
NEW YORK, July 25, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical…
Amarin Receives Positive Recommendation from Spanish Drug Pricing Committee for National Reimbursement of VAZKEPA® (icosapent ethyl) in Spain
— Spain’s Drug Pricing Committee recommends reimbursement of VAZKEPA® (icosapent ethyl) to reduce the risk…
Aquestive Therapeutics to Report Second Quarter 2023 Financial Results and Recent Business Highlights on August 7 and Host Conference Call on August 8 at 8:00 a.m. ET
WARREN, N.J., July 25, 2023 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST), (the “Company”…
NewAmsterdam Pharma Completes Enrollment in Pivotal Phase 3 BROADWAY Clinical Trial Evaluating Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia and/or Established Atherosclerotic Cardiovascular Disease
— Exceeded Target Enrollment; Expect to Randomize More Than 2,500 Patients — — Topline Results…
Iovance Biotherapeutics to Present Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Therapy at IASLC 2023 World Conference on Lung Cancer
Oral Presentation of Cohort 3A Data from IOV-COM-202 Phase 2 Clinical Trial of LN-145 in…
Pushpay Expands Giving Options, Announces Free Stock Donations with Engiven
Pushpay’s innovation in digital giving continues with new stock giving for churches REDMOND, Wash., July…
Wells Fargo & Company Increases Common Stock Dividend and Announces New $30 Billion Common Stock Repurchase Program
SAN FRANCISCO–(BUSINESS WIRE)–Wells Fargo & Company (NYSE: WFC) today announced its board of directors approved…
Trustmark Corporation Announces Second Quarter 2023 Financial Results
Loan and Deposit Growth Continues, Credit Quality Remains Strong, Net Interest Income and Noninterest Income…
Voiceitt celebrates 33rd anniversary of the Americans with Disabilities Act by endorsing groundbreaking Communications, Video, and Technology Accessibility Act of 2023
The Communications, Video, and Technology Accessibility Act (CVTA) Act, introduced by Senator Ed Markey and…
Arconic Shareholders Approve Acquisition by Apollo Funds
PITTSBURGH–(BUSINESS WIRE)–Arconic Corporation (NYSE: ARNC) (“Arconic” or the “Company”) announced today that its shareholders have…
Benitec Biopharma Announces 1-for-17 Reverse Stock Split Effective July 26, 2023
HAYWARD, Calif., July 25, 2023 (GLOBE NEWSWIRE) — Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or…
Business Warrior Corporation (BZWR) Introduces Marketing Services for Lenders
PHOENIX, July 25, 2023 (GLOBE NEWSWIRE) — Business Warrior Corporation (OTC: BZWR), the source for…
ISA Announces 2023 Automation and Leadership Conference
October event in Colorado Springs to include society meetings, technical presentations, career skills sessions, and…
Otterbourg Adds Adele Hogan as Head of Securities Practice
NEW YORK–(BUSINESS WIRE)–Otterbourg P.C. is pleased to announce the arrival of Adele Hogan as a…
Edge Impulse Launches Integration with NVIDIA TAO Toolkit to Supercharge Edge AI
Developers and enterprises can optimize performance and accelerate time to market of edge AI applications…
KBRA Assigns Preliminary Ratings to Cross 2023-H1 Mortgage Trust (CROSS 2023-H1)
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA assigns preliminary ratings to six classes of mortgage pass-through certificates from Cross…
Tiblio AI “Roger,” an AI-Powered Options Income Assistant, Integrates with TradeStation® Securities Brokerage Services
Roger includes continuous calculations and trade assistance LOS ANGELES–(BUSINESS WIRE)–Tiblio, Inc. today announced the integration…
IPSEN – Buy-back programme – Art 5 of MAR – Week 29 – 2023
Aggregated presentation by day and by market Name of issuer Identification code of issuer (Legal…
Nymox Reports Successful New NYMOZARFEX (TM) Long-Term Prostate Cancer Treatment Clinical Trial Results
NYMOZARFEX 15 mg Minimal Treatment of Low Grade Prostate Cancer Leads to Significant Long-Term Reduction…